BioSpace News Archive

Singapore scientists are developing a single test that can detect and differentiate multiple mosquito-borne viruses and their types

The project company Belina is running an innovative project in early phase and is developing a product for treatment of breast cancer.

Accenture recently published a new report, “New Science: Biopharma’s New Growth Machine.” In it, the report attempts to evaluate the last 20 years of trends in biopharma and use that data to develop projections for the future of the industry.

Biom’up announced that the U.S. Food and Drug Administration approved the IDE application for HEMOSNOW, a hemostatic dry powder made from porcine collagen and bovine-derived chondroitin sulfate developed by the Company for managing minimal and mild levels of bleeding during surgical procedures.

EpiCypher® announced the signing of an agreement with Thermo Fisher Scientific, the world leader in servicing science, to provide co-exclusive use of EpiCypher’s SNAP-ChIP® technology.

BioCity, a pioneering life science incubator and business collective, today announced investment in Deep Branch Biotechnology, a Nottingham-based carbon recycling start-up, developing technology that transforms polluters into producers.

Michigan-based health insurer Priority Health recorded a dramatic decrease in opioid use among the company’s membership across all business lines, a positive step forward in the ongoing opioid epidemic sweeping through the state and across the country.

Forge Therapeutics, Inc. (Forge) and Basilea Pharmaceutica International Ltd. (Basilea), a wholly-owned subsidiary of Basilea Pharmaceutica Ltd. [SIX: BSLN], announced today that they have entered into a research collaboration and license agreement to discover, develop, and commercialize novel antibiotic classes.

The global nephrology and urology devices market is expected to post a CAGR of over 5% during the period 2019-2023, according to the latest market research report by Technavio.

To continue meeting the needs of clients around the world, StemExpress announces the expansion of its existing distribution network in the Asia Pacific region, adding to their current partnerships with companies in North America, Europe, and North Africa.